Neil Mahant

Clinical Associate Professor Neil Mahant is affiliated with the University of Sydney's Faculty of Medicine and Health, specifically within the Sydney Medical School's Education Office. His research focuses on neurology, movement disorders, Parkinson's disease, dystonia, and stroke treatment. He has contributed to over 50 peer-reviewed publications since 2002, including studies on botulinum toxin therapy, deep brain stimulation, and genomic diagnostics in movement disorders.

Key research interests include device-assisted therapies for Parkinson’s disease, genetic underpinnings of dystonia, and advanced imaging techniques for neurodegenerative diseases. His work spans clinical trials (e.g., incobotulinumtoxinA for tremor), pharmacological interventions (levodopa-carbidopa intestinal gel), and neuroimaging applications in stroke management. Recent studies highlight the use of whole-genome sequencing for diagnostic clarity in heterogeneous dystonia cases.

Publications from 2021–2025 emphasize automated tremor measurement, dopamine transporter binding correlations in Parkinson’s, and cost-effectiveness analyses of botulinum toxin treatments. Earlier work (2002–2006) explored Huntington’s disease neuropathology and seizure mechanisms through computational models.

Mahant collaborates extensively with multidisciplinary teams, including neurologists, neurosurgeons, and biomedical engineers. His clinical practice integrates cutting-edge therapies with patient-centered care, particularly in movement disorder management and neurorehabilitation.